The curative effect in patients with systemic lupus erythematosus complicated by moderate or severe thrombocytopenia
10.3969/j.issn.1006-5725.2017.10.023
- VernacularTitle:系统性红斑狼疮患者并发中重度血小板减少症的疗效观察及相关因素分析
- Author:
Rongjun HUANG
;
Jing WEN
;
Jinglin GAO
;
Cheng ZHAO
- Keywords:
Lupus erythematosus;
Systemic;
Thrombocytopenia;
Megakaryocytes;
Treatment effectiveness
- From:
The Journal of Practical Medicine
2017;33(10):1619-1622
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the curative effect in patients with systemic lupus erythematosus(SLE) complicated by moderate or severe thrombocytopenia with a blood platelet count(BPC) of under 50 × 109/L and analyze its related factors. Methods We retrospectively analyzed the clinical data on 109 SLE patients with mod-erate or severe thrombocytopenia. Results Of the 109 patients,82(75.2%)had complete response(CR),15 (13.8%)had partial response(PR),and 12(11.0%)had no response(NR),respectively. As compared with the CR+PR group,the NR group had a higher incidence rate of decreased bone marrow megakaryocyte(P < 0.05). However,there were no significant differences between the two groups in SLEDAI scores,rates of positive PAIg and ACA,and levels of C3 and C4(P>0.05 for all comparisons). The total effectiveness rate did not differ signifi-cantly between MP pulse therapy and high-dose corticosteroid therapy. Conclusions A decrease in bone marrow megakaryocytes can be an adverse factorfor affecting the efficacy in patients with SLE complicated by moderate or severe thrombocytopenia.
